ClearBridge Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$63.4M Buy
125,764
+16,439
+15% +$8.69M 0.05% 279
2026
Q2
$58.7M Buy
109,325
+84,878
+347% +$43.5M 0.05% 311
2026
Q1
$12.8M Buy
+24,447
New +$11.7M 0.01% 441

Other funds holding MDGL

ClearBridge Investments's MDGL Position: Q3 2026 in Review

ClearBridge Investments increased its Madrigal Pharmaceuticals (MDGL) stake by 15% in Q3 2026, buying an estimated $8.69M and bringing the position to 125,764 shares worth $63.4M. The position accounts for 0.05% of the portfolio, ranked #279.

ClearBridge Investments first reported a position in MDGL in Q1 2026 and has held it in 3 quarters since. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • ClearBridge Investments held 125,764 shares of Madrigal Pharmaceuticals worth $63.4M as of Q3 2026.
  • ClearBridge Investments bought 16,439 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $8.69M.
  • Madrigal Pharmaceuticals made up 0.05% of ClearBridge Investments's portfolio in Q3 2026, its #279 holding.
  • ClearBridge Investments first reported a position in Madrigal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on ClearBridge Investments's 13F filing for Q3 2026, filed 12 Nov 2026.